P2X7 receptor activation-induced contraction and lysis in human saphenous vein smooth muscle

Circulation Research

Volumn 83, Issue 2, 1998, Pages 196-203

  Cario Toumaniantz, Chrystelle ^a   Loirand, Gervaise ^a   Ladoux, Annie ^a   Pacaud, Pierre ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Cation channel; Purinoceptor; Smooth muscle; Vein

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; IONOTROPIC RECEPTOR; PURINE P2X RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; RNA; 2',3' DIALDEHYDE ATP; 2',3'-DIALDEHYDE ATP; 2-METHYLTHIO-ATP; 3' O (4 BENZOYL)BENZOYLADENOSINE 5' TRIPHOSPHATE; 3'-O-(4-BENZOYL)BENZOYLADENOSINE 5'-TRIPHOSPHATE; ALPHA,BETA-METHYLENEADENOSINE 5'-TRIPHOSPHATE; DRUG DERIVATIVE; HYBRID PROTEIN; ION CHANNEL; MUSCLE PROTEIN; NUCLEOTIDE; PURINE P2 RECEPTOR; PURINE P2X7 RECEPTOR;

ADULT; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN TISSUE; ION CURRENT; MACROPHAGE; MALE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SAPHENOUS VEIN; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE; ANIMAL; CHANNEL GATING; DRUG EFFECT; GENETICS; ION TRANSPORT; METABOLISM; MIDDLE AGED; PATCH CLAMP; PHYSIOLOGY; POLYMERASE CHAIN REACTION; VASOCONSTRICTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; COS CELLS; FEMALE; HUMANS; ION CHANNEL GATING; ION CHANNELS; ION TRANSPORT; MALE; MIDDLE AGED; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; PATCH-CLAMP TECHNIQUES; POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P2; RECOMBINANT FUSION PROTEINS; SAPHENOUS VEIN; THIONUCLEOTIDES; VASOCONSTRICTION;

EID: 0032572415     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.2.196     Document Type: Article

References (33)

1. Pelleg A, Burnstock G. Physiological importance of ATP released from nerve terminals and its degradation to adenosine in humans. Circulation. 1990;82:2269-2272.
2. Sneddon P, Westfall DP. Pharmacological evidence that ATP and noradrenaline are cotransmitters in the guinea-pig vas deferens. J Physiol (Lond). 1984;347:561-580.
3. Evans RJ, Derkach V, Surprenant A. ATP mediates fast synaptic transmission in mammalian neurons. Nature. 1992;357:503-505.
4. Flavahan NA, Vanhoutte PM. Sympathetic purinergic vasoconstriction and thermosensitivity in a canine cutaneous vein. J Pharmacol Exp Ther. 1986;239:784-789.
5. Albino-Texeira A, Azevedo I, Branco D, Osswald W. Purine agonists prevent trophic changes caused by sympathetic denervation. Eur J Pharmacol. 1990;179:141-149.
6. North RA. Families of ion channels with two hydrophobic segments. Curr Opin Cell Biol. 1996;8:474-483.
7. 2X receptor for extracellular ATP. Nature. 1994;37:516-519.
8. North RA, Barnard EA. Nucleotide receptors. Curr Opin Neurobiol. 1997;7:346-357.
9. 6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci. 1996;16:2495-2507.
10. 2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol. 1993;265:C577-C606.
11. 7). Science. 1996;272:735-738.
12. 3 subunits can account for ATP-gated currents in sensory neurons. Nature. 1995;377:432-435.
13. 2+ in freshly isolated smooth muscle cells from human saphenous vein. Pflügers Arch. 1995;430:429-436.
14. 3 purinoceptor. Mol Brain Res. 1997;47:59-66.
15. Jurman ME, Boland LM, Yellen G. Visual identification of individual transfected cells for electrophysiology using antibody-coated beads. Biotechniques. 1994;17:876-881.
16. 2Z receptor. J Biol Chem. 1993;268:8199-8203.
17. 7. J Biol Chem. 1997;272: 5482-5486.
18. 2Z purinergic receptors expressed in Xenopus oocytes. J Biol Chem. 1994;269:13988-13996.
19. Welford LA, Cusack NJ, Hourani SMO. ATP analogues and the guinea-pig taenia coli: a comparison of the structure-activity relationships of ectonucleotidases with those of the P2-purinoceptor. Eur J Pharmacol. 1986;129:217-224.
20. Chen BC, Lin WW. Inhibition of ecto-ATPase by the P2 purinoceptor agonists, ATPγS, α,β-methylene-ATP, and AMP-PNP in endothelial cells. Biochem Biophys Res Commun. 1997;233:442-446.
21. Murgia M, Pizzo P, Steinberg TH, Di Virgilio F. Characterization of the cytotoxic effect of extracellular ATP in J774 mouse macrophages. Biochem J. 1992;288:897-901.
22. Khakh BJ, Kennedy C. Adenosine and ATP: progress in their receptors' structure and functions. Trends Pharmacol Sci. 1998;19:39-41.
23. 7 receptor: characterization of pore formation [abstract]. J Physiol (Lond). 1998;506P:45P.
24. Born GVR, Kratzer MAA. Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J Physiol (Lond). 1984;354:419-429.
25. Yang S, Cheek DJ, Westfall DP, Buxton ILO. Purinergic axis in cardiac blood vessels. Circ Res. 1994;74:401-407.
26. Ziganshin AU, Hoyle CHV, Burnstock G. Ecto-enzymes and metabolism of extracellular ATP. Drug Dev Res. 1994;32:134-146.
27. Kennedy C, Todorov LD, Mihaylova-Todorova S, Sneddon P. Release of soluble nucleotidases: a novel mechanism for neurotransmitter inactivation? Trends Pharmacol Sci. 1997;18:263-266.
28. Hoyle CHV, Burnstock G. Purines. In: Bittar EE, Bittar N, eds. Principle of Medical Biology. Greenwich, Conn: JAI Press Inc; 1996:49-75.
29. Michiels C, Arnould T, Houbion A, Remacle J. Human umbilical vein endothelial cells submitted to hypoxia-reoxygenation in vitro: implication of free radicals, xanthine oxidase and energy deficiency. J Cell Physiol. 1992;153:53-61.
30. Michiels C, Arnould T, Remade J. Hypoxia-induced activation of endothelial cells as a possible cause of venous diseases: a hypothesis. Angiology. 1993;44:639-646.
31. Lengyel I, Acsady G. Histomorphological and pathobiochemical changes of varicose veins: a possible explanation of the development of varicosis. Acta Morphol Hung. 1990;38:259-267.
32. Yagi K, Shinbo M, Hasizume M, Shimba LS, Kurimura S, Miura Y. ATP diphosphohydrolase is responsible for ecto-ATPase and ecto-ADPase activities in bovine aorta endothelial and smooth muscle cells. Biochem Biophys Res Commun. 1991;180:1200-1206.
33. Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW, Bach FH. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med. 1997;185:153-163.